UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...
Anthocyanins also help fight inflammation by neutralizing harmful free radicals and reducing oxidative stress. Why Do Rheumatoid Arthritis Symptoms Worsen During Monsoon? Avoid Eating Walnuts If You ...